Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Mallinckrodt
Daiichi Sankyo
Argus Health
Chubb
US Department of Justice
Colorcon
Medtronic
QuintilesIMS

Generated: December 10, 2017

DrugPatentWatch Database Preview

SOTRADECOL Drug Profile

« Back to Dashboard

When do Sotradecol patents expire, and when can generic versions of Sotradecol launch?

Sotradecol is a drug marketed by Elkins Sinn and Mylan Institutional and is included in two NDAs.

The generic ingredient in SOTRADECOL is sodium tetradecyl sulfate. There are one thousand four hundred drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sodium tetradecyl sulfate profile page.
Drug patent expirations by year for SOTRADECOL

Medical Subject Heading (MeSH) Categories for SOTRADECOL

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Elkins SinnSOTRADECOLsodium tetradecyl sulfateINJECTABLE;INJECTION005970-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan InstitutionalSOTRADECOLsodium tetradecyl sulfateINJECTABLE;INJECTION040541-002Nov 12, 2004RXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Elkins SinnSOTRADECOLsodium tetradecyl sulfateINJECTABLE;INJECTION005970-005Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan InstitutionalSOTRADECOLsodium tetradecyl sulfateINJECTABLE;INJECTION040541-001Nov 12, 2004RXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Queensland Health
Johnson and Johnson
Dow
Merck
Federal Trade Commission
US Department of Justice
Teva
Accenture
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot